Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiofrequency Ablation vs Antiarrhythmic Drugs for Pediatric PVCs
NCT02772354Phase 3Unknown
- Sponsor
- E. Meshalkin National Medical Research Centre
- Start
- Apr 2016
- Primary completion
- Sep 2017
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by E. Meshalkin National Medical Research Centre. Primary endpoint: Presence of premature ventricular complexes ≥ 300 according to the 24-hour Holter ECG monitoring. Status: unknown.
Beyond the preview
Go deeper on NCT02772354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02772354.